BI
ProShares - Ultra Nasdaq Biotechnology (BIB)
NASDAQ·Financial Services·Asset Management
$114.50
+3.09%
Mkt Cap $68.86M
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$209.30
Range $141.96 – $245.70
Implied Upside
+82.8%
Consensus $209.30 vs current $114.50